GISuser.com
Ayres Acquires True View 620 3D Imaging System
December 28, 2020 By Editor
HUNTSVILLE, AL – GeoCue Group has partnered with the Geospatial Division of consulting firm, Ayres, in their acquisition of a GeoCue True View 620 3D Imaging System (3DIS®).
GeoCue’s True View 620 is equipped with RIEGL’s miniVUX-2UAV laser scanner integrated with dual photogrammetric cameras. Extreme accuracy is provided by Applanix APX-20 Position and Orientation System. All True View 3D Imaging Systems are bundled with Applanix POSPac, True View EVO post-processing software and True View Reckon data management solution.
The True View 620 system is a compact, survey grade 3D Imaging Sensor designed for small Unmanned Aerial Systems (UAS). The 200 kHz, 5 return RIEGL laser scanner and dual photogrammetric cameras (providing 40 megapixels of imagery) have been carefully configured to provide a fused LIDAR/imagery field of view of 120°. All components are contained within a rigid m
Search jobs 21-Dec-2020 Counterfeit Drug Detection Device Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies
VALLEY COTTAGE, N.Y. – Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmaceutical product that is deliberately mislabeled with respect to identity and/or source. Counterfeit drugs may include branded and generic products, drugs with the correct ingredients or with the wrong ingredients; without active pharmaceutical ingredient (API), with insufficient active pharmaceutical ingredients (API) or with fake packaging (WHO 2012).
1.2 Research Methodology
2. Industry Overview
2.2 COVID-19 Has Increased the Challenges Faced by Hospitals
2.3 Digital Hospitals: Addressing Limitations of Traditional Providers Through Decentralized Care, Interoperable Systems, Outcome-Driven and Proactive Approaches
2.4 Improving Patient Journey in the Hospital Through Use of Smart Technologies
2.5 Virtual Assistant and Appointment Scheduling Platforms for Hassle-Free Pre-Hospitalization Experience for the Patients
2.6 Technologies for Enhancing Patients Experience During Hospitalization
2.7 Technologies Enabling Post-Operative Monitoring and Follow-Up Care for the Patients
2.8 Optimizing Energy Efficiency, Improving Asset Tracking and Inventory Management Through Deployment of Technologies
2.9 Digital Hospital Ecosystem Comprises of Technologies Used in Patient and Non-Patient Care
3. Medical Robots
3.2 Reducing Clinicians Workload Through Robot-Assisted Venipuncture and Hospital Supplies Transportation
Share this article
Share this article
NEW YORK, Dec. 15, 2020 /PRNewswire/ As per the World Health Organization (WHO), in 2018, 2.09 million cases, 2.08 million cases, 1.80 million cases, 1.28 million cases, 1.04 million cases, and 1.03 million cases of lung cancer, breast cancer, colorectal cancer, prostate cancer, skin cancer, and stomach cancer, respectively, were detected. Due to this factor, the global photoacoustic imaging market will likely witness a healthy 20.3% CAGR during 2020–2030, to grow to $279.3 million by 2030 from $39.8 million in 2019, says P&S Intelligence.
Photoacoustic imaging is used to look at the internal human anatomy, wherein the pictures are formed based on how much laser radiation is being absorbed by tissues or the contrast agent injected. In this regard, the photoacoustic imaging market is also being driven by the increasing prevalence of respiratory and cardiovascular diseases (CVDs). The WHO estimates the annual death count of CVDs at 17.9 mil
Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Size | Global Industry Analysis and Opportunity Assessment 2020-2025 marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.